LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹7.67 Cr | ₹0.70 Cr | ₹-1.88 Cr | ₹-4.50 Cr | ₹-0.70 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LINCOLN PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹7.67 Cr |
| Mar2024 | ₹0.70 Cr |
| Mar2023 | ₹-1.88 Cr |
| Mar2022 | ₹-4.50 Cr |
| Mar2021 | ₹-0.70 Cr |
How is Net Cash Inflow / Outflow of LINCOLN PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.67 Cr | 1,003.17 | |
| Mar2024 | ₹0.70 Cr | Positive | |
| Mar2023 | ₹-1.88 Cr | Negative | |
| Mar2022 | ₹-4.50 Cr | Negative | |
| Mar2021 | ₹-0.70 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,202.6 Cr | 3% | -5.3% | 14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 3% |
-5.3% |
14.4% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses